Orix (IX) Liabilities from Discontinued Operations (2011 - 2026)

Orix (IX) posted Liabilities from Discontinued Operations of $18.9 billion for Q2 2026, up 0.52% on a QoQ basis from $18.8 billion in Q1 2026.

Analysis

Orix (IX) Liabilities from Discontinued Operations (2011 - 2026) Analysis & Trends

Orix has reported Liabilities from Discontinued Operations for 4 years, with the latest figure at $18.9 billion in Q2 2026.

On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $18.9 billion in Q2 2026; TTM through Jun 2026 was $18.9 billion, a N/A change from a year earlier, with the FY2026 full-year figure at $19.6 billion, changed N/A from the prior year.
Liabilities from Discontinued Operations was $18.9 billion for Q2 2026 at Orix, up from $18.8 billion in the prior quarter.
The five-year high for Liabilities from Discontinued Operations was $18.9 billion in Q2 2026, with the low at $18.8 billion in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Orix	44.18 Bn	44.51 Bn	4.68 Bn
2	Royalty Pharma	33.59 Bn	35.70 Bn	-
3	Royal Gold	21.14 Bn	21.00 Bn	390.45 Mn
4	OR Royalties	6.88 Bn	6.81 Bn	82.22 Mn
5	Encore Capital	2.11 Bn	1.93 Bn	455.04 Mn
6	Atlanticus Holdings	1.41 Bn	851.50 Mn	686.46 Mn
7	Jefferson Capital	1.18 Bn	1.16 Bn	-
8	Lufax Holding	1.04 Bn	-1.23 Bn	-
9	Upbound	998.67 Mn	893.37 Mn	594.84 Mn
10	Metalla Royalty & Streaming	942.93 Mn	931.86 Mn	4.75 Mn

Historic Data

Download Data